Patients with primary associated sclerosing cholangitis and patients who have family histories of first-degree colorectal cancer require annual monitoring.
Los pacientes con colangitis esclerosante primaria asociada, o que tienen antecedentes familiares en primer grado de cáncer colorrectal, requieren vigilancia anual.